DK0624087T3 - Sprøjteafkølet nabumeton - Google Patents

Sprøjteafkølet nabumeton

Info

Publication number
DK0624087T3
DK0624087T3 DK93902444.4T DK93902444T DK0624087T3 DK 0624087 T3 DK0624087 T3 DK 0624087T3 DK 93902444 T DK93902444 T DK 93902444T DK 0624087 T3 DK0624087 T3 DK 0624087T3
Authority
DK
Denmark
Prior art keywords
spray
pct
umbilical
tone
cooled
Prior art date
Application number
DK93902444.4T
Other languages
English (en)
Inventor
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK0624087T3 publication Critical patent/DK0624087T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coating By Spraying Or Casting (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Freezing, Cooling And Drying Of Foods (AREA)
  • Catching Or Destruction (AREA)
  • Road Signs Or Road Markings (AREA)
  • Sampling And Sample Adjustment (AREA)
DK93902444.4T 1992-01-29 1993-01-22 Sprøjteafkølet nabumeton DK0624087T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929201857A GB9201857D0 (en) 1992-01-29 1992-01-29 Novel compound

Publications (1)

Publication Number Publication Date
DK0624087T3 true DK0624087T3 (da) 1997-09-01

Family

ID=10709436

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93902444.4T DK0624087T3 (da) 1992-01-29 1993-01-22 Sprøjteafkølet nabumeton

Country Status (24)

Country Link
US (1) US5539000A (da)
EP (1) EP0624087B1 (da)
JP (1) JPH07503245A (da)
KR (1) KR950700056A (da)
CN (1) CN1079954A (da)
AT (1) ATE150298T1 (da)
AU (1) AU3362693A (da)
BG (1) BG98933A (da)
BR (1) BR9305674A (da)
CA (1) CA2129027A1 (da)
CZ (1) CZ182894A3 (da)
DE (1) DE69309037T2 (da)
DK (1) DK0624087T3 (da)
ES (1) ES2099419T3 (da)
FI (1) FI943550L (da)
GB (1) GB9201857D0 (da)
GR (1) GR3023142T3 (da)
HU (1) HUT67462A (da)
IL (1) IL104526A0 (da)
MX (1) MX9300430A (da)
NO (1) NO942813D0 (da)
SK (1) SK91694A3 (da)
WO (1) WO1993014747A1 (da)
ZA (1) ZA93577B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
GB9920148D0 (en) * 1999-08-25 1999-10-27 Smithkline Beecham Plc Novel composition
US6436990B1 (en) 1999-10-27 2002-08-20 Nobex Corporation 6-methoxy-2-naphthylacetic acid prodrugs
TWI262791B (en) 1999-10-27 2006-10-01 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs
US6552078B2 (en) 1999-10-27 2003-04-22 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs
US20020132010A1 (en) * 2000-12-22 2002-09-19 Yihong Qui Divalproex sodium dosage forms and a process for their production
US20040161474A1 (en) * 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
US20060083791A1 (en) 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
JP2007513147A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 押し出し機を使用して、好ましくはポロキサマーとグリセリドを含有する多粒子結晶性医薬組成物を製造するための噴霧凝結方法
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
BRPI0416535A (pt) * 2003-12-04 2007-01-09 Pfizer Prod Inc processo de congelamento por vaporização empregando um extrusor para preparar composições de azitromicina de multiparticulado contendo preferivelmente um poloxámero e um glicerìdeo
WO2005053651A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
RU2331410C2 (ru) * 2003-12-04 2008-08-20 Пфайзер Продактс Инк. Способ получения фармацевтических мультичастиц
BRPI0417338A (pt) * 2003-12-04 2007-04-17 Pfizer Prod Inc formas de dosagem de azitromicina multiparticulada por processos a base de lìquido
US20060134225A1 (en) * 2004-10-15 2006-06-22 Moerck Rudi E Phosphate binder with reduced pill burden
WO2007022445A2 (en) * 2005-08-17 2007-02-22 Altairnano, Inc. Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods
US7541384B2 (en) * 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8436051B2 (en) 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
AU2011252983C1 (en) 2010-05-12 2015-02-19 Unicycive Therapeutics, Inc. Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016205423A2 (en) 2015-06-15 2016-12-22 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
EP3824296B1 (en) 2018-07-20 2026-04-01 Lipocine Inc. Oral pharmaceutical composition comprising testosterone tridecanoate and/or testosterone dodecanoate for treating liver diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420639C1 (en) * 1973-09-11 2001-08-21 Beecham Group Ltd Aromatic compounds
GB1474377A (en) 1973-09-11 1977-05-25 Beecham Group Ltd Naphthalene derivatives
US4086346A (en) * 1974-04-06 1978-04-25 Bayer Aktiengesellschaft Preparation of melt-sprayed spherical phenacetin granules
DE3833446A1 (de) * 1988-10-01 1990-04-05 Hoechst Ag Verfahren zur herstellung von arzneimittelwirkstoff-partikeln mit verbesserten fliess-, lager- und formulierungseigenschaften sowie arzneimittel, die diese arzneimittelwirkstoff-partikeln enthalten

Also Published As

Publication number Publication date
MX9300430A (es) 1994-08-31
HUT67462A (en) 1995-04-28
WO1993014747A1 (en) 1993-08-05
FI943550A0 (fi) 1994-07-28
US5539000A (en) 1996-07-23
CZ182894A3 (en) 1995-02-15
EP0624087A1 (en) 1994-11-17
GR3023142T3 (en) 1997-07-30
ZA93577B (en) 1994-01-13
DE69309037T2 (de) 1997-07-24
JPH07503245A (ja) 1995-04-06
EP0624087B1 (en) 1997-03-19
NO942813L (no) 1994-07-28
AU3362693A (en) 1993-09-01
IL104526A0 (en) 1993-05-13
CN1079954A (zh) 1993-12-29
CA2129027A1 (en) 1993-08-05
BR9305674A (pt) 2005-01-11
BG98933A (en) 1995-07-28
ATE150298T1 (de) 1997-04-15
NO942813D0 (no) 1994-07-28
KR950700056A (ko) 1995-01-16
ES2099419T3 (es) 1997-05-16
DE69309037D1 (de) 1997-04-24
FI943550A7 (fi) 1994-07-28
GB9201857D0 (en) 1992-03-18
FI943550L (fi) 1994-07-28
HU9402221D0 (en) 1994-09-28
SK91694A3 (en) 1995-03-08

Similar Documents

Publication Publication Date Title
DE69309037D1 (de) Sprüherstarrtes nabumeton
MX9100804A (es) Derivados de hidroxiurea hipoglucemica
GB2270075B (en) Substituted 2-phenyl-3-methoxypropenoate fungicides
GB9514473D0 (en) Chemical compounds
MX9800394A (es) Formulacion de liberacion sostenida de d-treo-metilfenidato.
AU695311B2 (en) Gamma-RAR antagonist ligand or alpha-RAR agonist ligand as an apoptosis inhibitor
MY132115A (en) Novel thrombin inhibitors
GR3015313T3 (en) Indole derivatives as antiallergy and antiinflammatory agents.
ATE182713T1 (de) Folien-schallabsorber
NO944406L (no) Nye 7 e inhibitorer
ES2162907T3 (es) 3-acilaminobenzacepinas.
NO943100L (no) Forbindelser for anvendelse i kontrastmidler for radiografi
FI951698A0 (fi) Kantajalla oleva katalyytti ja sen käyttö
MY106522A (en) Arylaminocarbonyl compounds.
FI934058A0 (fi) Foerfarande och anordning foer insblaosning av gas i en granulaer filterbaedd
NO973366L (no) Fremgangsmåte for behandling av multippel sklerose
FI953568A0 (fi) Kytkimen suojausjärjestely
GB9607119D0 (en) Compounds
ATE238403T1 (de) Kühlmittelzusammensetzungen
TW366338B (en) Arylalkoxyphenoxy-imidazoline compounds
FR2673346B1 (fr) Enceinte accoustique icosaedrique.
DK0711450T3 (da) Plenar-transducer.
FR2690326B1 (fr) Support mural d'objets, notamment des clés.
ES2149353T3 (es) Polimorfos a y b de 1-(difenilmetil)-4-(3-(2-fenil-1,3-dioxolan-2-il)propil)piperazina.
GB2302438A (en) Sounder